July 16, 2025Current Opinion in Oncology

High-risk smoldering myeloma – a case for early intervention?

View Full Paper

Ask AI

Bookmark

Authors

AKA. KrishnamoorthiOxford University Hospitals NHS Trust RVRohit VijjhalwarUniversity Hospital Southampton NHS Foundation Trust AKArun KannanNational University of Singapore

Discussion

Member takes

Implication

This review discusses the evolving risk stratification and treatment strategies for smoldering myeloma, highlighting early intervention's potential benefits.

Key Points

Early intervention could potentially improve outcomes for patients with high-risk smoldering myeloma, targeting disease eradication and sustained MRD negativity.
Risk stratification methodologies for smoldering myeloma have advanced, shifting diagnostics and treatment approaches for patient populations.
Ongoing trials are emphasizing intensive treatments and immunotherapies, aiming to refine strategies for managing smoldering myeloma effectively.
Further high-quality evidence is necessary to improve treatment protocols and patient outcomes in smoldering myeloma, especially in post-SLiM-CRAB classifications.

Cite This Study

Krishnamoorthi et al. (2025) studied this question.

synapsesocial.com/papers/68af6203ad7bf08b1eae2c4a https://doi.org/10.1097/cco.0000000000001182

View Full Paper

Ask AI

Bookmark

July 16, 2025Current Opinion in Oncology

High-risk smoldering myeloma – a case for early intervention?

View Full Paper

Ask AI

Bookmark

Authors

AKA. KrishnamoorthiOxford University Hospitals NHS Trust RVRohit VijjhalwarUniversity Hospital Southampton NHS Foundation Trust AKArun KannanNational University of Singapore

Discussion

Member takes

Implication

This review discusses the evolving risk stratification and treatment strategies for smoldering myeloma, highlighting early intervention's potential benefits.

Key Points

Early intervention could potentially improve outcomes for patients with high-risk smoldering myeloma, targeting disease eradication and sustained MRD negativity.
Risk stratification methodologies for smoldering myeloma have advanced, shifting diagnostics and treatment approaches for patient populations.
Ongoing trials are emphasizing intensive treatments and immunotherapies, aiming to refine strategies for managing smoldering myeloma effectively.
Further high-quality evidence is necessary to improve treatment protocols and patient outcomes in smoldering myeloma, especially in post-SLiM-CRAB classifications.

Cite This Study

Krishnamoorthi et al. (2025) studied this question.

synapsesocial.com/papers/68af6203ad7bf08b1eae2c4a https://doi.org/10.1097/cco.0000000000001182

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark